SEARCH

SEARCH BY CITATION

References

  • Appelbaum, F.R., Storb, R., Ramberg, R.E., Shulman, H.M., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R. & Thomas, E.D. (1984) Allogeneic marrow transplantation in the treatment of preleukemia. Annals of Internal Medicine, 100, 689693.
  • Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Carotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A. (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: An update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood, 95, 19311934.
  • Bean, M.A., Storb, R., Graham, T., Raff, R., Sale, G.E., Schuening, F. & Appelbaum, F.R. (1991) Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood. Transplantation, 52, 956960.
  • Boeckh, M., Gooley, T.A., Myerson, D., Cunningham, T., Schoch, G. & Bowden, R.A. (1996) Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood, 88, 40634071.
  • Champlin, R.E., Perez, W.S., Passweg, J.R., Klein, J.P., Camitta, B.M., Gluckman, E., Bredeson, C.N., Eapen, M. & Horowitz, M.M. (2007) Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood, 109, 45824585.
  • Deeg, H.J., Storb, R., Weiden, P.L., Raff, R.F., Sale, G.E., Atkinson, K., Graham, T.C. & Thomas, E.D. (1982) Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of tolerance. Transplantation, 34, 3035.
  • Doney, K., Leisenring, W., Storb, R. & Appelbaum, F.R. for the Seattle Bone Marrow Transplant Team (1997) Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Annals of Internal Medicine, 126, 107115.
  • Fouladi, M., Herman, R., Rolland-Grinton, M., Jones-Wallace, D., Blanchette, V., Calderwood, S., Doyle, J., Halperin, D., Leaker, M., Saunders, E.F., Zipursky, A. & Freedman, M.H. (2000) Improved survival in severe acquired aplastic anemia of childhood. Bone Marrow Transplantation, 26, 11491156.
  • Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandrasekar, P.H., Fox, B., Kaizer, H., Shadduck, R.K., Shea, T.C., Stiff, P., Friedman, D.J., Powderly, W.G., Silber, J.L., Horowitz, H., Lichtin, A., Wolff, S.N., Mangan, K.F., Silver, S.M., Weisdorf, D., Ho, W.G., Gilbert, G. & Buell, D. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine, 326, 845851.
  • Kahl, C., Leisenring, W., Deeg, H.J., Chauncey, T.R., Flowers, M.E.D., Martin, P.J., Sanders, J.E. & Storb, R. (2005) Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. British Journal of Haematology, 130, 747751.
  • Kalbfleisch, J.D. & Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data. John Wiley & Sons, New York.
  • Kennedy-Nasser, A.A., Leung, K.S., Mahajan, A., Weiss, H.L., Arce, J.A., Gottschalk, S., Carrum, G., Khan, S.P., Heslop, H.E., Brenner, M.K., Bollard, C.M. & Krance, R.A. (2006) Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biology of Blood and Marrow Transplantation, 12, 12771284.
  • Kobayashi, R., Yabe, H., Hara, J., Morimoto, A., Tsuchida, M., Mugishima, H., Ohara, A., Tsukimoto, I., Kato, K., Kigasawa, H., Tabuchi, K., Nakahata, T., Ohga, S. & Kojima, S. (2006) Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. British Journal of Haematology, 135, 693696.
  • Koc, S., Leisenring, W., Flowers, M.E.D., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Storb, R., Appelbaum, F.R. & Martin, P.J. (2002) Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood, 100, 4851.
  • Limaye, A.P., Huang, M.-L., Leisenring, W., Stensland, L., Corey, L. & Boeckh, M. (2001) Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. Journal of Infectious Diseases, 183, 377382.
  • Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J. & Fuhrer, M. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 92, 1118.
  • Locatelli, F., Bruno, B., Zecca, M., Van-Lint, M.T., McCann, S., Arcese, W., Dallorso, S., Di Bartolomeo, P., Fagioli, F., Locasciulli, A., Lawler, M. & Bacigalupo, A. (2000) Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood, 96, 16901697.
  • Martin, P.J. (2009) Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Thomas' Hematopoietic Cell Transplantation (ed. by F.R. Appelbaum, S.J. Forman, R.S. Negrin & K.G. Blume), pp. 365. Wiley-Blackwell, Oxford, UK.
  • Martin, P.J., McDonald, G.B., Sanders, J.E., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Nash, R.A., Petersdorf, E.W., Hansen, J.A. & Storb, R. (2004) Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 10, 320327.
  • Pepe, M.S., Longton, G. & Thornquist, M. (1991) A qualifier Q for the survival function to describe the prevalence of a transient condition. Statistics in Medicine, 10, 413421.
  • Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.-G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825828.
  • Pulsipher, M.A., Young, N.S., Tolar, J., Risitano, A.M., Deeg, H.J., Anderlini, P., Calado, R., Kojima, S., Eapen, M., Harris, R., Scheinberg, P., Savage, S.E., Maciejewski, J.P., Tiu, R.V., Difronzo, N., Horowitz, M.M. & Antin, J.H. (2011) Optimization of therapy for severe aplastic anemia based on clinical, biological, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biology of Blood and Marrow Transplantation, 17, 291299.
  • Rosenfeld, S.J., Kimball, J., Vining, D. & Young, N.S. (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood, 85, 30583065.
  • Sanders, J.E., Woolfrey, A.E., Carpenter, P.A., Storer, B.E., Hoffmeister, P.A., Deeg, H.J., Flowers, M.E.D. & Storb, R.F. (2011) Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood, 118, 14211428.
  • Santos, G.W. & Owens, Jr, A.H. (1969) Allogeneic marrow transplants in cyclophosphamide treated mice. Transplantation Proceedings, 1, 4446.
  • Scheinberg, P., Nunez, O., Wu, C. & Young, N.S. (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. British Journal of Haematology, 133, 606611.
  • Scheinberg, P., Wu, C.O., Nunez, O. & Young, N.S. (2008) Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. Journal of Pediatrics, 153, 814819.
  • Scheinberg, P., Wu, C.O., Nunez, O. & Young, N.S. (2009a) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. British Journal of Haematology, 144, 206216.
  • Scheinberg, P., Wu, C.O., Nunez, O., Scheinberg, P., Boss, C., Sloand, E.M. & Young, N.S. (2009b) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica, 94, 348354.
  • Scheinberg, P., Cooper, J.N., Sloand, E.M., Wu, C.O., Calado, R.T. & Young, N.S. (2010) Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia [Erratum appears in JAMA. 2010 Nov 3;304(17):1901]. Journal of the American Medical Association, 304, 13581364.
  • Schrezenmeier, H., Passweg, J.R., Marsh, J.C., Bacigalupo, A., Bredeson, C.N., Bullorsky, E., Camitta, B.M., Champlin, R.E., Gale, R.P., Fuhrer, M., Klein, J.P., Locasciulli, A., Oneto, R., Schattenberg, A.V., Socie, G. & Eapen, M. (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood, 110, 13971400.
  • Storb, R., Epstein, R.B., Rudolph, R.H. & Thomas, E.D. (1969) Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation, 7, 378386.
  • Storb, R., Buckner, C.D., Dillingham, L.A. & Thomas, E.D. (1970a) Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Research, 30, 21952203.
  • Storb, R., Epstein, R.B., Rudolph, R.H. & Thomas, E.D. (1970b) The effect of prior transfusion on marrow grafts between histocompatible canine siblings. Journal of Immunology, 105, 627633.
  • Storb, R., Prentice, R.L. & Thomas, E.D. (1977) Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. New England Journal of Medicine, 296, 6166.
  • Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Goodell, B.W., Sale, G.E., Sanders, J.E., Singer, J., Stewart, P. & Weiden, P.L. (1980) Marrow transplantation in thirty “untransfused” patients with severe aplastic anemia. Annals of Internal Medicine, 92, 3036.
  • Storb, R., Doney, K.C., Thomas, E.D., Appelbaum, F., Buckner, C.D., Clift, R.A., Deeg, H.J., Goodell, B.W., Hackman, R., Hansen, J.A., Sanders, J., Sullivan, K., Weiden, P.L. & Witherspoon, R.P. (1982) Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood, 59, 236246.
  • Storb, R., Prentice, R.L., Sullivan, K.M., Shulman, H.M., Deeg, H.J., Doney, K.C., Buckner, C.D., Clift, R.A., Witherspoon, R.P., Appelbaum, F.R., Sanders, J.E., Stewart, P.S. & Thomas, E.D. (1983) Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Annals of Internal Medicine, 98, 461466.
  • Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R. & Thomas, E.D. (1986a) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 68, 119125.
  • Storb, R., Deeg, H.J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Farewell, V., Hansen, J., Hill, R., Lum, L., Martin, P., McGuffin, R., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Yee, G. & Thomas, E.D. (1986b) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New England Journal of Medicine, 314, 729735.
  • Storb, R., Weiden, P.L., Sullivan, K.M., Appelbaum, F.R., Beatty, P., Buckner, C.D., Clift, R.A., Doney, K.C., Hansen, J., Martin, P.J., Sanders, J.E., Stewart, P., Witherspoon, R.P. & Thomas, E.D. (1987) Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood, 70, 116121.
  • Storb, R., Deeg, H.J., Fisher, L.D., Appelbaum, F., Buckner, C.D., Bensinger, W., Clift, R., Doney, K., Irle, C., McGuffin, R., Martin, P., Sanders, J., Schoch, G., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R. & Thomas, E.D. (1988) Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood, 71, 293298.
  • Storb, R., Deeg, H.J., Pepe, M., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Anasetti, C., Martin, P., Loughran, T.P., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R. & Thomas, E.D. (1989) Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial. British Journal of Haematology, 72, 567572.
  • Storb, R., Etzioni, R., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Bensinger, W., Bryant, E., Clift, R., Deeg, H.J., Doney, K., Flowers, M., Hansen, J., Martin, P., Pepe, M., Sale, G., Sanders, J., Singer, J., Sullivan, K.M., Thomas, E.D. & Witherspoon, R.P. (1994) Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood, 84, 941949.
  • Storb, R., Blume, K.G., O'Donnell, M.R., Chauncey, T., Forman, S.J., Deeg, H.J., Hu, W.W., Appelbaum, F.R., Doney, K., Flowers, M.E.D., Sanders, J. & Leisenring, W. (2001) Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biology of Blood and Marrow Transplantation, 7, 3944.
  • Strasser, S.I., Myerson, D., Spurgeon, C.L., Sullivan, K.M., Storer, B., Schoch, H.G., Kim, S., Flowers, M.E.D. & McDonald, G.B. (1999) Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology, 29, 18931899.
  • Stucki, A., Leisenring, W., Sandmaier, B.M., Sanders, J., Anasetti, C. & Storb, R. (1998) Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year old retrospective analysis). Blood, 92, 27422749.
  • Sullivan, K.M., Agura, E., Anasetti, C., Appelbaum, F.R., Badger, C., Bearman, S., Erickson, K., Flowers, M., Hansen, J.A., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadak, M., Storb, R. & Witherspoon, R.P. (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology, 28, 250259.
  • Young, N.S. (1995) Aplastic anaemia [Review]. Lancet, 346, 228232.